Novotech and CNS Deal Expands CRO Services

Published on: 

Applied Clinical Trials

Novotech, an Asia-Pacific-based CRO, has acquired Australasian specialist CRO Clinical Network Services (CNS) as part of a mission in hopes to expand services to biopharma for early phase product development and clinical research through to later phase regional and global trials.

Read the full release here.